Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.18 | 15.12 |
| PEG Ratio (TTM) | 0.05 | -0.22 |
| P/S Ratio (TTM) | 1.75 | 3.93 |
| P/B Ratio (TTM) | 0.62 | 2.92 |
| P/FCF Ratio (TTM) | 52.73 | 15.37 |
| Price to 5YR AVG Earnings Ratio | -5.43 | 37.87 |
| Price to 5YR AVG FCF Ratio | 17.60 | 22.26 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.05% | 10.13% |
| ROE (TTM) | 2.30% | 19.03% |
| Net Profit Margin (TTM) | 6.22% | -40.31% |
| ROIC 5YR AVG | -12.35% | 23.84% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -37.64% | -37.69% | 15.19% |
| Revenue | 7.94% | 81.91% | 67.52% |
| Net Income | -37.23% | -70.76% | -2.17% |
| Cash Flow | 111.54% | 16,587.48% | 9,995.41% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.10 | 1.72 |
| Quick Ratio (TTM) | 2.10 | 1.60 |
| D/E Ratio (TTM) | N/A | 16.17 |
| Interest Coverage (TTM) | 46.40 | 18.18 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 4.21 | 2.90 |
| LTL to 5YR AVG FCF | 0.06 | 15.40 |
| Shares Outstanding Growth 5YR AVG | 83.80% | 17.62% |